These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16080969)

  • 21. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of pre-procedural high-sensitivity C-reactive protein is associated with midterm restenosis after extra- and intracranial stenting.
    Gupta R; Bhatt A; Kassab M; Majid A
    J Neuroimaging; 2010 Jan; 20(1):74-7. PubMed ID: 19021830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
    Kaneda H; Honda Y; Morino Y; Lansky AJ; Yock PG; Bonan R; Fitzgerald PJ
    J Interv Cardiol; 2006 Oct; 19(5):376-80. PubMed ID: 17020560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
    Kumar R; Lee TT; Jeremias A; Ruisi CP; Sylvia B; Magallon J; Kirtane AJ; Bigelow B; Abrahamson M; Pinto DS; Ho KK; Cohen DJ; Carrozza JP; Cutlip DE
    Am J Cardiol; 2007 Oct; 100(8):1187-91. PubMed ID: 17920355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Fujita H; Inoue N; Takahashi H; Ono T
    Nephrol Dial Transplant; 2006 Jun; 21(6):1640-7. PubMed ID: 16431887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance in nondiabetic patients with acute myocardial infarction.
    Nishio K; Shigemitsu M; Kusuyama T; Fukui T; Kawamura K; Itoh S; Konno N; Katagiri T
    Cardiovasc Revasc Med; 2006; 7(2):54-60. PubMed ID: 16757401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
    Alidoosti M; Salarifar M; Zeinali AM; Kassaian SE; Dehkordi MR
    BMC Cardiovasc Disord; 2007 Mar; 7():7. PubMed ID: 17335586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restenosis after coronary stenting--incidence and predictors.
    Gupta A; Kerkar PG; Vajifdar BU; Lokhandwala YY; Vora AM; Kulkarni H
    J Assoc Physicians India; 2001 Mar; 49():336-42. PubMed ID: 11291973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
    Nishimura M; Takahashi H
    Rinsho Byori; 2011 Aug; 59(8):795-800. PubMed ID: 21942090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold coating and restenosis after primary stenting of ostial renal artery stenosis.
    Zeller T; Müller C; Frank U; Bürgelin K; Sinn L; Horn B; Roskamm H
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):1-6; discussion 7-8. PubMed ID: 12929094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-hospital and late clinical outcomes of direct stenting strategy versus stenting after predilatation for the treatment of coronary artery lesions.
    Alidoosti M; Salarifar M; Kassaian SE; Zeinali AH; Dehkordi MR; Fathollahi MS
    Indian Heart J; 2008; 60(4):318-24. PubMed ID: 19242009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.
    Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D
    Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis.
    Inoue T; Uchida T; Yaguchi I; Sakai Y; Takayanagi K; Morooka S
    Circulation; 2003 Apr; 107(13):1757-63. PubMed ID: 12665491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting.
    Piatti P; Di Mario C; Monti LD; Fragasso G; Sgura F; Caumo A; Setola E; Lucotti P; Galluccio E; Ronchi C; Origgi A; Zavaroni I; Margonato A; Colombo A
    Circulation; 2003 Oct; 108(17):2074-81. PubMed ID: 14530196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.